Abbott Laboratories reports a robust Q1 2025 with revenue hitting $10.4 billion, up 4% year-on-year, and net earnings growing 8.2% to $1.3 billion. CEO Robert Ford credits the comp...
Abbott Laboratories reports a 4% increase in Q1 2025 revenue to $10.4B and an 8.2% rise in net earnings to $1.3B, with EPS up by 8.6%. CEO Robert Ford highlights the company's dive...
Abbott Laboratories reports a 4% revenue increase to $10.4 billion and an 8.2% rise in net earnings to $1.3 billion in Q1 2025, with CEO Robert Ford highlighting the strength of it...
Abbott Laboratories reports a significant 8.2% profit increase in Q1 2025, with revenues up to $10.4 billion. CEO Robert Ford highlights the company's diversified business model as...
Abbott Laboratories reports a strong start to 2025 with a 4% revenue increase to $10.4 billion and an 8.2% rise in net earnings to $1.3 billion in Q1, alongside reaffirmed 2025 gro...
Abbott Laboratories reports a 4% increase in Q1 revenue to $10.4 billion and an 8.2% rise in net earnings to $1.3 billion, with CEO Robert Ford crediting the company's diversified ...
Abbott Laboratories reports a 4% revenue increase to $10.4 billion and an 8.2% rise in net earnings to $1.3 billion in Q1 2025, with CEO Robert Ford attributing success to the comp...
